Brief: Landos Biopharma Q4 Net Income USD -6.119 Million
21/03/2024 12:00
Mar 21 (Reuters) - Landos Biopharma Q4 operating expenses USD 6.61 million. * Q4 operating income USD -6.61 million * Q4 basic EPS USD -0.99
Recent news on Landos Biopharma
See all newsLandos Biopharma Inc expected to post a loss of 100 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Super Micro, Micron Technology, Navios Maritime
U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Brief: AbbVie To Acquire Landos Biopharma